Nordic Pharma Lab ApS: Financial statements 2018
CVR: 39161672
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -11,340 and a net result of DKK -11,340. Equity amounted to DKK 88,660. The solvency ratio was 92.2%.
- Gross Profit
- -11,340 kr.
- Profit/Loss
- -11,340 kr.
- Equity
- 88,660 kr.
- Total Assets
- 96,160 kr.
Keep an eye on Nordic Pharma Lab ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
On January 11, 2018, the company changed its name from ApS STM nr. 6145 to Nordic Pharma Lab ApS.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity amounted to DKK -429,426.
